Clark Capital Management Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Clark Capital Management Group’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-29,995	Closed	-$1.71M	–	347
2019 Q4	$1.71M	Buy	29,995 +4,230	+16%	+$224K	0.04%	198
2019 Q3	$1.38M	Sell	25,765 -792	-3%	-$46.1K	0.03%	202
2019 Q2	$1.59M	Sell	26,557 -10,527	-28%	-$662K	0.03%	194
2019 Q1	$2.31M	Buy	+37,084	New	+$2.45M	0.06%	175

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Clark Capital Management Group's BSTC Position: Q1 2020 in Review

Clark Capital Management Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2020, closing a stake of 29,995 shares — an estimated $1.71M sold.

Clark Capital Management Group first reported a position in BSTC in Q1 2019 and held it in 4 quarters. The position peaked at $2.31M in Q1 2019. 113 funds tracked by Wall St. Rank hold BSTC as of Q1 2020.

Clark Capital Management Group reported no remaining BioSpecifics Technologies Corp. position as of Q1 2020 after selling out during the quarter.
Clark Capital Management Group sold 29,995 BioSpecifics Technologies Corp. shares in Q1 2020, an estimated $1.71M.
Clark Capital Management Group first reported a position in BioSpecifics Technologies Corp. in Q1 2019 and held it in 4 quarters.
Clark Capital Management Group's BioSpecifics Technologies Corp. position peaked at $2.31M in Q1 2019.
113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2020.

Based on Clark Capital Management Group's 13F filing for Q1 2020, filed 15 May 2020.